Clinical TrialsSearch results
Number of results: 683
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- adult T-cell leukemia / lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-17
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18
Other
- Neoadjuvant and adjuvant chemotherapy with ifosfamide and adriamycin for adult high-grade soft tissue sarcomas in the extremities (JCOG0304, Neoadjuvant and adjuvant chemotherapy with IFO/ADM phase II)
- soft tissue sarcoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Evaluation of feasibility and accuracy of diagnosis using sentinel node biopsy in early gastric cancer(JCOG0302, GCSSG-SNB)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- CHOP therapy for low and low-intermediate risk patients of advanced aggressive non-Hodgkin's lymphoma (JCOG9508, LSG17(CHOP))
- low and low-intermediate risk of aggressive non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-09
Other
- Accelerated fractionation vs. conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study (JCOG0701)
- T1-2N0M0 glottic cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-05
Other
- A Randomized PhaseII/III Study of Concurrent Chemoradiotherapy with Low Dose Cisplatin plus 5-FU versus Concurrent Chemoraiotherapy with Standard Dose Cisplatin plus 5-FU for Locally Advanced Unresetable Esophageal Cancer in the Thorax.(JCOG0303)
- Locally advanced unresectable esophageal cancer in the thorax
- Japan Clinical Oncology Group(JCOG)
- 2007-10-23
Other
- A randomized phase II/III study of ACNU versus Procarbazine plus ACNU as a postoperative chemoradiotherapy for strocytoma grade 3 and 4(JCOG0305, ACNU+PCZ PhaseII/III)
- astrocytoma grade 3/4
- Japan Clinical Oncology Group(JCOG)
- 2005-09-02